Endovascular left atrial appendage occlusion in nonvalvular atrial fibrillation
A.S. Postojalko, S.A. Sivak, M.I. Kudash, S.S. Galitskaya
The aim of the study was to investigate the immediate and follow up results of the first Belarus experience of transcatheter left atrial appendage occlusion with the Watchman device in patients with nonvalvular atrial fibrillation.
keywords: atrial fibrillation, transcatheter occlusion, stroke, left atrial appendage
for references: A.S. Postojalko, S.A. Sivak, M.I. Kudash, S.S. Galitskaya. Transcatheter left atrial appendage occlusion in nonvalvular atrial fibrillation: the first republican experience in terms of world data. Emergency Cardiology and CardiovascularRisks. 2018, vol. 2, № 2, pp. 373-376
[1] Meier B., Blaauw Y., Khattab A.A., Lewalter T., Sievert H., Tondo C., Glikson M. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace, 2014, vol. 16, № 10, pp. 1397-1416. doi: 10.1093/europace/euu174. Epub 2014 Aug 29.
[2] Ganeeva O.N. Okkljuzija ushka levogo predserdija pri fibrilljacii predserdij [Left atrial appendage occlusion in atrial fibrillation]. Patologija krovoobrashhenija i kardiohirurgija, 2014, vol. 18, № 4, pp. 104-112. (in Russian).
[3] Heeringa J, van der Kuip D.A, Hofman A., Kors J.A., van Herpen G., Stricker B.H., Stijnen T., Lip G.Y., Witteman J.C. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J, 2006, vol. 27, № 8, pp. 949-953.
[4] Kishore A., Vail A., Majid A., Dawson J., Lees K.R., Tyrrell P.J., Smith C.J. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke, 2014, vol. 45, № 2, pp. 520-526.
[5] Bedeir K., Holmes D.R., Cox J.L., Ramlawi B. Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation. J Thorac Cardiovasc Surg, 2017, vol. 153, № 5, pp. 1097-105.
[6] Chatterjee S., Alexander J.C., Pearson P.J., Feldman T. Left atrial appendage occlusion: lessons learned from surgical and transcatheter experiences. Ann Thorac Surg, 2011, vol. 92, № 6, pp. 2283-2292.
[7] Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B., Castella M., Diener H.C., Heidbuchel H., Hendriks J., Hindricks G., Manolis A.S., Oldgren J., Popescu B.A., Schotten U., Van Putte B., Vardas P. ESC Guidelances for the management of atrial fibrillation developed in collaboration with EACTS. Kardiol Pol, 2016, vol. 74, № 12, pp. 1 3 5 9 -1 4 6 9 . doi: 10.5603/ KP.2016.0172.
[8] Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, vol. 146, № 12, pp. 857-867.
[9] Cooper N.J., Sutton A.J., Lu G., Khunti K. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med, 2006, vol. 166, № 12, pp. 1269-1275.
[10] Waldo A.L., Becker R.C., Tapson V.F., Colgan K.J. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol, 2005, vol. 46, № 9, pp. 1729-1736.
[11] Brown M.T., Bussel J.K. Medication adherence: WHO cares? Mayo Clin Proc, 2011, vol. 86, № 4, pp. 304-314. doi: 10.4065/mcp.2010.0575. Epub 2011 Mar 9.
[12] Ruff C.T., Giugliano R.P., Braunvald E., Hoffman E.B., Deenadayalu N., Ezekowitz M.D., Camm A.J., Weitz J.I., Lewis B.S., Parkhomenko A., Yamashita T., Antman E.M. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a metaanalysis of randomised trials. Lancet, 2014, vol. 383, № 9921, pp. 955962. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4.
[13] Meier B., Palacios I., Windecker S., Rotter M., Cao Q.L., Keane D., Ruiz C.E., Hijazi Z.M. Transcatheter left atrial appendage closure with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv, 2011, vol. 60, № 3, pp. 417-422.
[14] Shahmatova O.O. Jendovaskuljarnaja okkljuzija ushka levogo predserdija ustrojstvom Watchman kak al’ternativnyj podhod k profilaktike trom - bojembolicheskih oslozhnenij u pacientov s fibrilljaciej predserdij [Transcatheter left atrial appendage occlusion with Watchman device as an alternative method of prevention of thromboembolic events]. Aterotromboz, 2013, № 2, pp. 30-37. (in Russian).
[15] Holmes D.R., Doshi S.K., Kar S., Price M.J., Sanchez J.M., Sievert H., Valderrabano M., Reddy V.Y. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation.: a patient-level metaanalysis. J Am Coll Cardiol, 2015, vol. 65, № 24, pp. 2614-2623. doi: 10.1016/j.jacc.2015.04.025.
[16] Gangireddy S.R., Halperin J.L., Fuster V., Reddy V.Y. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. Eur Heart J 2012, vol. 33, № 21, pp. 2700-2708. doi: 10.1093/eurheartj/ehs292. Epub 2012 Sep 24.
[17] Alli O., Doshi S., Kar S., Reddy V., Sievert H., Mullin C., Swarup V., Whise- nant B., Holmes D.Jr. Quality of life assessment in the randomized PROTECT AF trial of patients at risk for stroke with non-valvular atrial fibrillation. J Am Coll Cardiol, 2013, vol. 61, № 17, pp. 1790-1798. doi: 10.1016/j.jacc.2013.01.061. Epub 2013 Feb 28.
